Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,292 | 39,246 | 53,393 | 16,376 | 23,649 |
| Marketable Securities | 770 | 1,333 | 1,825 | 1,852 | 7,024 |
| Receivables | 3,683 | 2,986 | 1,125 | 2,384 | 2,361 |
| Other current assets | 0 | 0 | 0 | 62 | 62 |
| TOTAL | $13,745 | $43,565 | $56,343 | $20,674 | $33,096 |
| Non-Current Assets | |||||
| PPE Net | 2,575 | 12,233 | 8,206 | 4,047 | 4,076 |
| Other Non-Current Assets | 4,960 | 5,712 | 0 | 0 | 0 |
| TOTAL | $7,535 | $17,945 | $8,206 | $4,047 | $4,076 |
| Total Assets | $21,280 | $61,510 | $64,549 | $24,721 | $37,172 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,342 | 7,656 | 5,747 | 1,920 | 1,315 |
| TOTAL | $8,342 | $7,656 | $5,747 | $1,920 | $1,315 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,403 | 309 | 0 | 97 | 327 |
| TOTAL | $1,403 | $309 | $N/A | $97 | $327 |
| Total Liabilities | $9,745 | $7,965 | $5,747 | $2,017 | $1,642 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24 | N/A | N/A | 143 | 143 |
| Common Shares | 727 | 727 | 727 | 727 | 727 |
| Retained earnings | -189,423 | -141,824 | -98,281 | -62,625 | -49,799 |
| Other shareholders' equity | 0 | 0 | 0 | -378 | -378 |
| TOTAL | $11,535 | $53,545 | $58,802 | $22,704 | $35,530 |
| Total Liabilities And Equity | $21,280 | $61,510 | $64,549 | $24,721 | $37,172 |